Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("REESINK, H. W")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 116

  • Page / 5
Export

Selection :

  • and

Blood transfusion and hepatitis: still a threat?REESINK, H. W; VAN DER POEL, C. L.Blut. 1989, Vol 58, Num 1, pp 1-6, issn 0006-5242Article

Evaluation of three second-generation and three confirmatory assays for antibodies to human immunodeficiency virusLELIE, P. N; REESINK, H. W; HUISMAN, H et al.Vox sanguinis (Basel. 1956). 1988, Vol 54, Num 2, pp 84-91, issn 0042-9007Article

Detection of bacterial contamination of platelet concentratesPIETERSZ, R. N. I; ENGELFRIET, C. P; REESINK, H. W et al.Vox sanguinis (Basel. 1956). 2003, Vol 85, Num 3, pp 224-239, issn 0042-9007, 16 p.Article

Survival in vivo of platelets stored for 48 hours in the buffycoat at 4°C compared to platelet rich plasma stored at 22°CPIETERSZ, R. N. I; LOOS, J. A; REESINK, H. W et al.Blut. 1987, Vol 54, Num 4, pp 201-206, issn 0006-5242Article

Inactivation of 12 viruses by heating steps applied during manufacture of a hepatitis B vaccineLELIE, P. N; REESINK, H. W; LUCAS, C. J et al.Journal of medical virology. 1987, Vol 23, Num 3, pp 297-301, issn 0146-6615Article

Preparation of leukocyte-poor platelet concentrates from buffy coats. I. Special inserts for centrifuge cupsPIETERSZ, R. N. I; REESINK, H. W; DEKKER, W. J. A et al.Vox sanguinis (Basel. 1956). 1987, Vol 53, Num 4, pp 203-207, issn 0042-9007Article

Compodock, a new device for sterile dockingVAN DERMEER, P. F; BIEKART, F. T; PIETERSZ, R. N. I et al.Transfusion (Philadelphia, PA). 2000, Vol 40, Num 6, pp 682-686, issn 0041-1132Article

Automated separation of whole blood in top and bottom bags into components using the Compomat G4VAN DER MEER, P. F; PIETERSZ, R. N. I; HINLOOPEN, B et al.Vox sanguinis (Basel. 1956). 1999, Vol 76, Num 2, pp 90-99, issn 0042-9007Article

Consequences of nucleic acid amplification testing for blood transfusion centresREESINK, H. W; ENGELFRIET, C. P; PRATI, D et al.Vox sanguinis (Basel. 1956). 1998, Vol 74, Num 4, pp 263-270, issn 0042-9007Article

Stability of hepatitis C virus RNA during specimen handling and storage prior to NASBA amplificationDAMEN, M; SILLEKENS, P; SJERPS, M et al.Journal of virological methods. 1998, Vol 72, Num 2, pp 175-184, issn 0166-0934Article

Use of cord blood progenitor cells as an alternative for bone marrow transplantationENGELFRIET, C. P; REESINK, H. W; DENEYS, V et al.Vox sanguinis (Basel. 1956). 1998, Vol 75, Num 2, pp 156-172, issn 0042-9007Article

Donor selection : The exclusion of high risk donors?VAN DEN BURG, P. J. M; VRIELINK, H; REESINK, H. W et al.Vox sanguinis (Basel. 1956). 1998, Vol 74, pp 499-502, issn 0042-9007, SUP2Conference Paper

What are the consequences of indeterminate results in confirmatory tests for antibodies against transmissible viruses?REESINK, H. W; ENGELFRIET, C. P; SIRCHIA, G et al.Vox sanguinis (Basel. 1956). 1997, Vol 73, Num 2, pp 97-104, issn 0042-9007Article

New strip immunoblot for the confirmation of HTLV-I/II infectionVRIELINK, H; ZAAIJER, H. L; PICHUANTES, S et al.Vox sanguinis (Basel. 1956). 1996, Vol 70, Num 2, pp 114-116, issn 0042-9007Article

Sensitivity and specificity of four assys to detect human T-lymphotropic virus type I or type I/II antibodiesVRIELINK, H; REESINK, H. W; ZAAIJER, H. L et al.Transfusion (Philadelphia, PA). 1996, Vol 36, Num 4, pp 344-346, issn 0041-1132Article

What is the best technique for the detection of red cell alloantibodies ?ENGELFRIET, C. P; REESINK, H. W; GERBER, H et al.Vox sanguinis (Basel. 1956). 1995, Vol 69, Num 3, pp 292-300, issn 0042-9007Article

Comparison of quantitative cDNA-PCR with the branched DNA hybridization assay for monitoring plasma hepatitis C virus RNA levels in haemophilia patients participating in a controlled interferon trialBRESTERS, D; CUYPERS, H. T. M; REESINK, H. W et al.Journal of medical virology. 1994, Vol 43, Num 3, pp 262-268, issn 0146-6615Article

Blood substitutes based on modified hemoglobinBAKKER, J. C; BLEEKER, W. K.Vox sanguinis (Basel. 1956). 1994, Vol 67, pp 139-142, issn 0042-9007, SUP3Conference Paper

Changing relationships between blood donors, community physicians and blood centersSAYERS, M. H.Vox sanguinis (Basel. 1956). 1994, Vol 67, pp 261-264, issn 0042-9007, SUP3Conference Paper

Cryopreservation of red blood cellsROWE, A. W.Vox sanguinis (Basel. 1956). 1994, Vol 67, pp 201-206, issn 0042-9007, SUP3Conference Paper

Immunity in hepatitis C virus infectionPRINCE, A. M.Vox sanguinis (Basel. 1956). 1994, Vol 67, pp 227-228, issn 0042-9007, SUP3Conference Paper

Organization of blood transfusion services in developing countriesKOISTINEN, J.Vox sanguinis (Basel. 1956). 1994, Vol 67, pp 247-249, issn 0042-9007, SUP3Conference Paper

Production of human therapeutic proteins in transgenic animalsHOYER, L. W; DROHAN, W. N; LUBON, H et al.Vox sanguinis (Basel. 1956). 1994, Vol 67, pp 217-220, issn 0042-9007, SUP3Conference Paper

Storage in synthetic medium and leuko-depletion of platelet concentratesBERTOLINI, F; REBULLA, P; MARANGONI, F et al.Vox sanguinis (Basel. 1956). 1994, Vol 67, pp 155-158, issn 0042-9007, SUP3Conference Paper

The clinical role of hematopoietic growth factors in peripheral blood progenitor cell transplantationFETSCHER, C; BRUGGER, W; MARTELSMANN, R et al.Vox sanguinis (Basel. 1956). 1994, Vol 67, pp 43-47, issn 0042-9007, SUP3Conference Paper

  • Page / 5